中文摘要 |
Dextromethorphan (DM) is a well known N-methyl-D-aspartate (NMDA) receptor antagonist and has a long history of clinical safety as an antititussive drug for 5 decades. The discovery of the N-methyl-D-aspartate (NMDA) receptor and its links to pain processing and spinal neural hyper-excitability provoked renewed interest in DM as a potential post-operative analgesic drug. This paper reviews the use and results of DM in the management of acute postoperative pain. Animal studies show that NMDA receptor antagonists may prevent induction of spinal hyper-excitability and development of central excitability. The previous review article by McCartney et al. showed that DM can produce significant preventive analgesia in 67% of DM studies reviewed. A preventive analgesia may reduce central sensitization induced by perioperative inputs. The efficacy of preventive analgesia is demonstrated as a reduction in postoperative pain intensity and/or analgesic use exceeds the expected clinical duration of action of the target preventive drug. Studies show that oral route or low doses of DM correlated with poor analgesia. In addition, DM administered parenteral routes (IM or IV) provided superior analgesia postoperatively with reduction of acute postoperative pain and analgesic consumption. The literature reviews suggest that postoperative pain control can be improved with the perioperative proper usage of DM as an adjunct to opioids, NSAIDs and local anesthetics in patients receiving various surgeries. The enhanced perioperatively analgesic effects of DM with negligible side effects appear to depend on the route of administration (oral, IV. or IM) as well as proper dosages (oral 90 mg, IM 40 mg, IV 0.5 mg/kg). |